PU-H71 HCl
Product Specifications
CAS Number
2095432-24-7
Target
HSP|||DNA/RNA Synthesis
Related Pathways
Cytoskeletal Signaling|||DNA Damage/DNA Repair|||Metabolism|||Cell Cycle/Checkpoint
Purity
0.9945
Bioactivity
PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT. PU-H71 HCL shows antitumor activity in many preclinical models of malignancy. PU-H71 HCL has an inhibitory effect on the protein expression levels of Rad51 and Ku70, which may be associated with the double chain break repair in the homologous recombination pathway and non-homologous end-joining pathway.
Smiles
Cl.IC=1C=C2OCOC2=CC1SC3=NC=4C(=NC=NC4N3CCCNC(C)C)N
Molecular Formula
C18H22ClIN6O2S
Molecular Weight
548.83
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6323358-01 0.1 mL
MYL6B, ID (MYL6B, MLC1SA, Myosin light chain 6B, Myosin light chain 1 slow-twitch muscle A isoform, Smooth muscle and nonmuscle myosin light chain alkali 6B) (MaxLight 490)
Ask
View Details MBS6323358-02 5x 0.1 mL
MYL6B, ID (MYL6B, MLC1SA, Myosin light chain 6B, Myosin light chain 1 slow-twitch muscle A isoform, Smooth muscle and nonmuscle myosin light chain alkali 6B) (MaxLight 490)
Ask
View Details 
